Eml is still a spec company, with a short history of profits and some execution risks, given the time it’s taken to roll out some of the major deals they have (and have entered years ago). But if they get it right then who cares about waiting around - - especially considering ebitda is growing at +40% yoy
- Forums
- ASX - By Stock
- EML
- 5 Broker Recommendations - Average PT $3.47
5 Broker Recommendations - Average PT $3.47, page-5
Featured News
Add EML (ASX) to my watchlist
(20min delay)
|
|||||
Last
67.0¢ |
Change
-0.040(5.63%) |
Mkt cap ! $253.4M |
Open | High | Low | Value | Volume |
70.0¢ | 70.0¢ | 66.5¢ | $1.111M | 1.635M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 109155 | 66.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
67.0¢ | 4999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 95155 | 0.665 |
10 | 178848 | 0.660 |
5 | 91592 | 0.655 |
11 | 114407 | 0.650 |
1 | 8646 | 0.645 |
Price($) | Vol. | No. |
---|---|---|
0.670 | 4999 | 1 |
0.675 | 8646 | 1 |
0.680 | 32439 | 3 |
0.685 | 9826 | 2 |
0.690 | 28646 | 2 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
EML (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online